当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析

益佰制药

(600594)

  

流通市值:31.76亿  总市值:31.76亿
流通股本:7.92亿   总股本:7.92亿

益佰制药(600594)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.11亿元,每股收益-0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益259468.25万元,未分配利润74459.73万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产399490.28万元,负债140022.03万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入501,480,776.322,174,031,578.871,713,840,317.371,168,191,423.5
营业总成本512,206,331.732,434,804,131.131,842,847,294.111,265,385,630.58
营业利润-10,478,077.98-312,253,471.83-163,471,482.03-106,432,218.92
利润总额-9,999,543.04-332,520,712.29-173,766,399.26-114,024,543.41
净利润-11,427,837.53-334,673,987.38-174,241,819.86-110,973,983.57
其他综合收益--198,981.0627,008.8339,540.83
综合收益总额-11,427,837.53-334,872,968.44-174,214,811.03-110,934,442.74
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,685,288,665.381,750,026,094.891,732,617,097.291,943,499,023.39
非流动资产合计2,309,614,143.352,349,675,146.592,434,540,393.752,462,359,121.94
资产总计3,994,902,808.734,099,701,241.484,167,157,491.044,405,858,145.33
流动负债合计914,345,074.87949,012,491.4867,216,658.471,067,252,716.75
非流动负债合计485,875,269.94544,578,448.63523,165,200.58483,552,120.29
负债合计1,400,220,344.811,493,590,940.031,390,381,859.051,550,804,837.04
归属于母公司股东权益合计2,480,372,737.032,489,758,456.492,648,055,698.322,725,723,383.53
股东权益合计2,594,682,463.922,606,110,301.452,776,775,631.992,855,053,308.29
负债和股东权益合计3,994,902,808.734,099,701,241.484,167,157,491.044,405,858,145.33
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计531,101,158.222,556,944,851.72,067,422,269.771,492,763,687.85
经营活动现金流出小计523,574,806.092,470,071,814.821,867,618,947.161,289,666,943.49
经营活动产生的现金流量净额7,526,352.1386,873,036.88199,803,322.61203,096,744.36
投资活动现金流入小计22,486.812,486,881.4112,293,621.4111,518,621.41
投资活动现金流出小计6,671,319.56116,323,71068,679,525.8948,336,191.55
投资活动产生的现金流量净额-6,648,832.76-103,836,828.59-56,385,904.48-36,817,570.14
筹资活动现金流入小计222,999,999.5560,000,000380,000,000238,784,183.37
筹资活动现金流出小计287,809,022.8719,706,367.19611,209,313.27367,520,000.97
筹资活动产生的现金流量净额-64,809,023.3-159,706,367.19-231,209,313.27-128,735,817.6
汇率变动对现金及现金等价物的影响-1,248.57-3,249.09-12,532-
现金及现金等价物净增加额-63,932,752.5-176,673,407.99-87,804,427.1437,543,356.62
期末现金及现金等价物余额455,074,557.37519,007,309.87607,876,290.72733,224,074.48
TOP↑